Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Alzheimers Dement. 2021 Apr 1;17(10):1675–1686. doi: 10.1002/alz.12334

Table 2:

Sample Characteristics

Variable Controls (n=53) AD (n=78) DLB (n=110) Overall p-value Post-hoc AD vs DLB
Age, y 67.6 (10.0) 79.7 (8.0) 77.7 (7.6) <.001 .23
Sex, %M 30.8 44.9 72.7 <.001 <.001
Education, y 16.1 (2.2) 15.2 (2.8) 15.4 (2.8) .17 .91
Hachinski 0.5 (0.6) 0.7 (0.8) 0.9 (1.1) .02 .15
FAQ 0.1 (0.5) 13.6 (8.5) 17.0 (8.9) <.001 <.001
NPI 1.4 (1.9) 7.6 (5.5) 10.2 (6.5) <.001 .002
UPDRS 2.7 (3.5) 5.4 (6.4) 23.8 (16.4) <.001 <.001
Hoehn & Yahr 0.2 (0.5) 0.3 (0.8) 2.5 (1.1) <.001 <.001
CDR 0.0 (0.0) 1.3 (0.7) 1.6 (0.8) <.001 <.001
CDR-SB 0.1 (0.2) 6.6 (3.6) 8.7 (4.8) <.001 <.001
 Memory 0.0 (0.0) 1.3 (0.7) 1.4 (0.7) <.001 .19
 Orientation 0.0 (0.1) 1.2 (0.8) 1.3 (0.8) <.001 .02
 Judgment/Problem Solving 0.1 (0.2) 1.4 (0.7) 1.8 (0.8) <.001 <.001
 Community Affairs 0.0 (0.0) 1.1 (0.7) 1.5 (0.8) <.001 <.001
 Home/Hobbies 0.0 (0.0) 1.1 (0.8) 1.6 (0.9) <.001 <.001
 Personal Care 0.0 (0.0) 0.5 (0.7) 1.2 (1.0) <.001 <.001

Mean (SD) or %

KEY: AD=Alzheimer’s disease; DLB=Dementia with Lewy bodies; FAQ=Functional Activities Questionnaire; NPI=Neuropsychiatric Inventory; UPDRS=Unified Parkinson’s Disease Rating Scale; CDR=Clinical Dementia Rating; CDR-SB=CDR Sum of boxes

Bold indicates post-hoc significance for AD vs DLB after correction for multiple comparisons (corrected p-value<.003)